City

San Diego (1)

Santo Domingo (1)

Condition

Interdigital Tinea Pedis (3)

Overall Status

Terminated (2)

Completed (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

AmDerma (1)

DermBiont, Inc. (1)

Taro Pharmaceuticals USA (1)

Collaborator

AmDerma Pharmaceuticals, LLC (1)

Intervention

butenafine hydrochloride 1% (1)

butenafine hydrochloride 1% b (1)

cohort 1 j. lividum (1)

econazole nitrate (1)

placebo (1)

placebo gel (1)

vehicle a (1)

vehicle b (1)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

Industry (3)

Study Type

Interventional (3)

interdigital tinea pedis

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Interdigital Tinea Pedis Trial in Santo Domingo (Cohort 1 J. Lividum, Placebo Gel)

Terminated

Interdigital Tinea Pedis

Cohort 1 J. Lividum
Placebo Gel

Santo Domingo, Dominican Republic

Instituto Dermatologico y Cirugia de Piel

Jun 16, 2021

Interdigital Tinea Pedis Trial (Butenafine Hydrochloride 1%, Butenafine Hydrochloride 1% B, Vehicle A)

Terminated

Interdigital Tinea Pedis

Butenafine Hydrochloride 1%
+3 more

(no location specified)

May 5, 2014

Interdigital Tinea Pedis Trial in San Diego (Econazole Nitrate, )

Completed

Interdigital Tinea Pedis

Econazole Nitrate
placebo

San Diego, California

Therapeutics Inc.

Sep 28, 2012